ARCA Biopharma Inc
NASDAQ:ABIO

Watchlist Manager
ARCA Biopharma Inc Logo
ARCA Biopharma Inc
NASDAQ:ABIO
Watchlist
Price: 2.4 USD -4% Market Closed
Market Cap: 10.9B USD

Intrinsic Value

The intrinsic value of one ABIO stock under the Base Case scenario is hidden USD. Compared to the current market price of 2.4 USD, ARCA Biopharma Inc is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

ABIO Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case
Compare ABIO to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Management
Loading...
Contacts
Loading...
Bear Theses

ARCA Biopharma’s lead candidate Gencaro remains highly dependent on regulatory success in challenging late-stage trials for atrial fibrillation and heart failure, creating vulnerability to pipeline setbacks that could sharply diminish the company’s valuation.

Bull Theses

If Gencaro successfully clears regulatory hurdles for atrial fibrillation in heart failure patients, ARCA Biopharma would command a first-mover advantage in a specialized genetic subset, offering significant pricing power and revenue potential.

Show More Less
How do you feel about ABIO?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about ARCA Biopharma Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
ARCA Biopharma Inc

Current Assets 33.8m
Cash & Short-Term Investments 33.3m
Other Current Assets 537k
Non-Current Assets 24k
PP&E 12k
Other Non-Current Assets 12k
Efficiency

Free Cash Flow Analysis
ARCA Biopharma Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
ARCA Biopharma Inc

Revenue
0 USD
Operating Expenses
-9.1m USD
Operating Income
-9.1m USD
Other Expenses
1.9m USD
Net Income
-7.2m USD
Fundamental Scores

ABIO Profitability Score
Profitability Due Diligence

ARCA Biopharma Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROIC
ROE is Increasing
Negative Free Cash Flow
Negative Operating Income
hidden
Profitability
Score

ARCA Biopharma Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

ABIO Solvency Score
Solvency Due Diligence

ARCA Biopharma Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
hidden
Solvency
Score

ARCA Biopharma Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ABIO Price Targets Summary
ARCA Biopharma Inc

There are no price targets for ABIO.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for ABIO is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
Lowest
Average
Highest
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

ABIO Insider Trading
Buy and sell transactions by insiders

ABIO News

Other Videos